Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.47 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.42 |
| ▸ | THRA | P10827 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.38 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | ICMT | O60725 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL847665 | 0.94 | TDP1 (0.64) | TDP1MCHR1SERPINE1THRATHRB | |
| SCHEMBL21990522 | 0.84 | TDP1 (0.62) | TDP1S1PR3CA2CA12CA1 | |
| Octadecylamine SCHEMBL9548499 | 0.84 | TDP1 (0.62) | TDP1S1PR3CA2CA12CA1 | |
| Tetrabuthylammonium SCHEMBL7765608 | 0.82 | TDP1 (0.64) | TDP1S1PR3KCNH2CA2CA1 | |
| SCHEMBL593014 | 0.82 | MCHR1 (0.68) | TDP1MCHR1SERPINE1THRATHRB | |
| SCHEMBL29163226 | 0.82 | MCHR1 (0.68) | TDP1MCHR1SERPINE1THRATHRB | |
| SCHEMBL27266882 | 0.80 | TSHR (0.53) | TDP1MCHR1KCNH2DRD3ICMT | |
| Trolamine SCHEMBL3410426 | 0.80 | TDP1 (0.70) | TDP1CA2CA12CA1VCAM1 | |
| SCHEMBL27165608 | 0.79 | TDP1 (0.64) | TDP1S1PR3CA2CA12CA1 | |
| SCHEMBL31651451 | 0.79 | THRA (0.56) | MCHR1THRATHRBKCNH2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | TOSOH FINECHEM CORPORATION (JP) | 2025-03-20 | — | — | US | claimed |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | TOSOH FINECHEM CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| WO-2023171597-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACIDS DERIVED THEREFROM AND POLYMERS THEREOF, AND METHODS FOR PRODUCING SAME | 東ソー・ファインケム株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | TOSOH FINECHEM CORPORATION (JP) | 2022-10-04 | — | — | US | disclosed |
| CN-110997631-B | High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof | 东曹精细化工株式会社 | 2022-07-15 | — | — | CN | disclosed |
| EP-3666753-A1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | Tosoh Finechem Corporation (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172643-A1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | TOSOH FINECHEM CORPORATION (JP) | 2020-06-04 | — | — | US | disclosed |
| CN-110997631-A | High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof | 东曹精细化工株式会社 | 2020-04-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | SLC7A1, ARSA, STS | TDP1 3230/4885MCHR1 1229/4885SERPINE1 4857/4885 |
| US-20200172643-A1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | SLC7A1, ARSA, STS | TDP1 3230/4885MCHR1 1229/4885SERPINE1 4857/4885 |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | BRPF1, WEE2, WEE1 | TDP1 1046/4885MCHR1 4082/4885SERPINE1 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.